US Novavax Also Verifies Efficacy Against 'Variant COVID'... Results Expected in a Few Weeks
[Asia Economy Reporter Seulgina Jo] American pharmaceutical company Novavax is currently verifying whether its novel coronavirus (COVID-19) vaccine is effective against the UK variant of the virus.
According to CNN, Novavax stated on the 28th (local time), "we are actively conducting serum tests to counter the UK variant." These tests involve collecting blood from clinical trial participants who received the Novavax vaccine and checking whether their antibodies neutralize the variant virus. The company expects it will take several weeks to obtain results.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
Not only Novavax, but Pfizer, Moderna, and others have also begun testing the efficacy of their vaccines against the variant virus. The UK variant is known to have approximately 70% higher transmissibility compared to the original virus.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
